Literature DB >> 9210048

Low-grade gliomas: introduction and overview.

J M Piepmeier1, S Christopher.   

Abstract

This issue of the Journal of Neuro-Oncology is devoted to recent investigations of low-grade gliomas. The purpose of this issue is not to debate the relative merits and liabilities of different management strategies for low-grade gliomas, but to present new data concerning novel and innovative approaches to evaluating these lesions. The common theme of many of these reports represents a departure from grading systems that primarily depend on a morphology-based analysis from light microscopy to classify these tumors. The purpose of this review is to present the reasoning behind the selection of authors for this issue of the Journal of Neuro-Oncology and to provide a format for presentation of new ideas concerning these interesting tumors. It is clear that standard classification systems that address only the morphological characteristics of tumor cells can not adequately represent the wide variation in biological activity that is found with these lesions. It is hoped that these articles will stimulate further interest and research into low-grade gliomas that will one day lead to more effective therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9210048     DOI: 10.1023/a:1005798901779

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  Suspected low-grade glioma: is deferring treatment safe?

Authors:  L D Recht; R Lew; T W Smith
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

2.  Prognostic implications of the proliferative potential of low-grade astrocytomas.

Authors:  T Hoshino; L A Rodriguez; K G Cho; K S Lee; C B Wilson; M S Edwards; V A Levin; R L Davis
Journal:  J Neurosurg       Date:  1988-12       Impact factor: 5.115

3.  Supratentorial low-grade astrocytomas in adults.

Authors:  J H Philippon; S H Clemenceau; F H Fauchon; J F Foncin
Journal:  Neurosurgery       Date:  1993-04       Impact factor: 4.654

4.  Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres.

Authors:  J M Piepmeier
Journal:  J Neurosurg       Date:  1987-08       Impact factor: 5.115

5.  Chromosomal composition of a series of 22 human low-grade gliomas.

Authors:  J A Rey; M J Bello; J M de Campos; M E Kusak; S Moreno
Journal:  Cancer Genet Cytogenet       Date:  1987-12

6.  Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma.

Authors:  L D Lunsford; S Somaza; D Kondziolka; J C Flickinger
Journal:  J Neurosurg       Date:  1995-04       Impact factor: 5.115

7.  Early prognosis of supratentorial grade 2 astrocytomas in adult patients after resection or stereotactic biopsy. An analysis of 50 cases operated on between 1984 and 1988.

Authors:  H J Steiger; R V Markwalder; R W Seiler; U Ebeling; H J Reulen
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

8.  Postoperative radiotherapy of supratentorial low-grade gliomas.

Authors:  E G Shaw; B W Scheithauer; D T Gilbertson; D A Nichols; E R Laws; J D Earle; C Daumas-Duport; J R O'Fallon; R P Dinapoli
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-03       Impact factor: 7.038

Review 9.  Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography.

Authors:  F T Vertosick; R G Selker; V C Arena
Journal:  Neurosurgery       Date:  1991-04       Impact factor: 4.654

10.  Low-grade astrocytomas: treatment results and prognostic variables.

Authors:  C A Medbery; K L Straus; S M Steinberg; J D Cotelingam; W S Fisher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-10       Impact factor: 7.038

View more
  2 in total

Review 1.  The role of surgery in low grade gliomas.

Authors:  J Bampoe; M Bernstein
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 2.  Complications and expected outcome of glioma surgery.

Authors:  K P Vives; J M Piepmeier
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.